Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats

Hypertension

Volumn 30, Issue 4, 1997, Pages 796-802

  Makino, Naoki ^a   Sugano, Masahiro ^a   Otsuka, Shoji ^a   Hata, Tomoji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin receptor; Cardiac hypertrophy; Rats, inbred SHR; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030876455     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.796     Document Type: Article

References (46)

1. Adams MA, Bobik A, Korner PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension: relation to sympathetic function. Hypertension. 1989;14:191-202.
2. Korner P, Bobik A, Oddie C, Friberg P. Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension 1993;22:243-252.
3. Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibitions improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
4. Johnson CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994; 23:258-268.
5. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH. Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res. 1995;76:489-497.
6. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
7. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227-241.
8. Makino N, Matsui H, Masutomo K, Hata T, Yanaga T. Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy. Mol Cell Biochem. 1993;119:23-28.
9. Unger T, Mattfeldt T, Lamberty V, Bock P, Linz W, Scholkens BA, Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension. 1992;20:478-482.
10. Nagasawa K, Zimmermann R, Munkel B, Linz W, Scholkens B, Schaper J. Extracellular matrix deposition in hypertensive hearts: antifibrotic effects of ramipril. Eur Hear J. 1995;16(suppl C):33-37.
11. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linz W, Scholkens BA, Wiemer G, Unger T. Long-term low-dose angiotensin-converting enzyme inhibition treatment increases vascular cyclic guanine 3′,5′-monophosphate. Hypertension. 1993;22:682-687.
12. Makino N, Sugano M, Hata T, Yanaga T. Chronic low dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy. Mol Cell Biochem. 1996;164:239-245.
13. Korner P, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1995;25(part 1):610-619.
14. Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
15. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblast. Circ Res. 1993;72:1245-1254.
16. Yoshida H, Kakuchi J, Guo DF, Furuta H, Iwai N, Jong R, Inagami T, Ichikawa I. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun. 1992;186:1042-1049.
17. Gaspaso M, Husain A, Alexander W, Catt KJ, Chiu AT, Frew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;45:205-251.
18. Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine B, LeJemtel T, DeKock M. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation. 1993;88(part 1):1602-1609.
19. Ichiki T, Labosky PA, Shiota C, Okuyama S, Inagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
20. Hei L, Barsh GS, Pratt RE, Dzau VJ, Koblika BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
21. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res. 1996;79:887-897.
22. Widdop RE, Gardiner SM, Kemp PA, Benett T. Central administration of PD123319 or EXP-3174 inhibits effects of angiotensin II. Am J Physiol. 1993;264:H117-H125.
23. Hayakari M, Kondoh Y, Ihumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem 1978;84:361-369.
24. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1961;35:1961-1965.
25. Mukherjee D, Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. 1991;88:1141-1146.
26. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol. 1996;28:507-517.
27. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
28. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-653.
29. Fort PH, Marty I, Piechaczyk M, Sabrouty SEI, Dani CH, Jeanteur PH, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
30. Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res. 1984;54:286-293.
31. Rogg H, Schmid A, de Gaspano M. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun. 1990;173:416-422.
32. Childs TJ, Adams MA, Mak AS. Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension. 1990;16:662-668.
33. Brilla CG, Janicki JS, Weber KT. Cardioprotective effects of lisinoprilin rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
34. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86:1913-1920.
35. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res. 1996;79:887-897.
36. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H. Angiotensin type 1 receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissue of hypertensive rats. J Pharmacol Exp Ther. 1995;273:509-515.
37. Vacher E, Fornes P, Richer C, Bruneval P, Nisato D, Giudicelli JF. Early and late hemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development. J Hypertens. 1995;13:675-682.
38. Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z, Ying W, Mizuni T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation. 1994;89:2204-2211.
39. Panizo A, Pardo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens. 1995;8:815-822.
40. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors. J Biol Chem. 1993;268:24539-24542.
41. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
42. 2 angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci U S A. 1991;88: 11440-11444.
43. 2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921-933.
44. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663-10667.
45. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
46. Yamada T, Horiuchi M, Dzau V. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996; 93:156-160.